Yun Dai

机构：Peking University, Peking University First Hospital · ORCID：0000-0002-8854-631X

发表论文 95 篇 · 总被引 3595 次 · h-index 26

代表论文

• Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota (2022 · Frontiers in Microbiology · 被引 54)
• Efficacy and safety of vonoprazan–amoxicillin dual therapy for Helicobacter pylori first-line treatment: a single-center, randomized, controlled trial (2023 · Therapeutic Advances in Gastroenterology · 被引 31)
• M11: A Tropism-Modified Oncolytic Adenovirus Arming with a Tumor-Homing Peptide for Advanced Ovarian Cancer Therapies (2022 · Human Gene Therapy · 被引 15)
• Empirical versus tailored therapy based on genotypic resistance detection for Helicobacter pylori eradication: a systematic review and meta-analysis (2023 · Therapeutic Advances in Gastroenterology · 被引 14)
• Constructing a highly sensitive duplex immunoassay using AuNPs and AgNPs as nanolabels for investigating the epithelial-mesenchymal transition occurring on circulating tumor cells with lung cancer patients (2024 · Biosensors and Bioelectronics · 被引 13)
• Vonoprazan–minocycline dual therapy as a first-line treatment of Helicobacter pylori infection compared with empirical bismuth-containing quadruple therapy (2025 · Therapeutic Advances in Gastroenterology · 被引 8)